To ID or not to ID? Changes in classification rates of intellectual disability using DSM-5.

Schizophrenia-risk variant rs6994992 in the neuregulin-1 gene on brain developmental trajectories in typically developing children.

Automated MRI parcellation of the frontal lobe.

Autism and anxiety in males with fragile X syndrome: an exploratory analysis of neurobehavioral profiles from a parent survey.

Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome.

Development of DNA damage response signaling biomarkers using automated, quantitative image analysis.

Development of socio-communicative skills in 9- to 12-month-old individuals with fragile X syndrome.

Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome.

Three different profiles: early socio-communicative capacities in typical Rett syndrome, the preserved speech variant and normal development.

Small molecule glutaminase inhibitors block glutamate release from stimulated microglia.

The NIH Toolbox Cognition Battery: results from a large normative developmental sample (PING).

Developmental delay in Rett syndrome: data from the natural history study.

Cyclobutane Pyrimidine Dimer Density as a Predictive Biomarker of the Biological Effects of Ultraviolet Radiation in Normal Human Fibroblast.

MeCP2 deficiency enhances glutamate release through NF-ÎşB signaling in myeloid derived cells.

Is activation of the intra-S checkpoint in human fibroblasts an important factor in protection against UV-induced mutagenesis?